We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

EEG Objectification in Neuropsychiatry

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2011 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01476228
First Posted: November 22, 2011
Last Update Posted: November 22, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Hadassah Medical Organization
  Purpose
The main objective of the study is to evaluate the use of EEG in the management and follow-up of neuropsychiatric disorders. Secondary objectives are therefore better understanding of the pathological activations in neural network during neuropsychiatric disorders, their clinical evolution and response to therapies.

Condition Intervention
Personality Disorder Depression Neurodegeneration Alzheimer's Disease Epilepsy Device: EEG recording

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: EEG Objectification in Neuropsychiatry

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • percentage of fitting (0-100%) of EEG pattern to a previously identified electrophysiological "key" [ Time Frame: 1 year ]
    The study will decode an EEG-based "key" (or electrophysiological pattern) for specific effect (such as the use of anti-epileptic agent or a certain condition) by comparing EEG before and after the use of this agent. For each patient the statistical fitting of the recorded EEG to the key will be evaluated by percentage (0-100%), describing fitting of the individual patient's EEG to the identified key.


Estimated Enrollment: 100
Study Start Date: November 2011
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: study group
EEG recording
Device: EEG recording
EEG recording

Detailed Description:
Patients are having EEG recordings as a routine part of their clinical evaluation and diagnosis. EEG recording is harmless, has no side effects, any radiation or any mechanical or electrical influence. It is of short duration and may be done in the EEG institute or the patient's room.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 90 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • diagnosis of the investigated neuropsychiatric disease

Exclusion Criteria:

  • Other co-existing neuropsychiatric conditions
  • Refusal to participate in the study
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01476228


Contacts
Contact: shahar arzy, MD PhD shahar.arzy@gmail.com

Locations
Israel
HMO Not yet recruiting
Jerusalem, Israel, 91120
Contact: Shahar Arzy, MD PhD    97226777741    shahar.arzy@gmail.com   
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: shahar arzy, MD PhD HMO
  More Information

Publications:
Responsible Party: Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01476228     History of Changes
Other Study ID Numbers: 0394-11-HMO-CTIL
First Submitted: August 22, 2011
First Posted: November 22, 2011
Last Update Posted: November 22, 2011
Last Verified: August 2011

Additional relevant MeSH terms:
Alzheimer Disease
Personality Disorders
Nerve Degeneration
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Tauopathies
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders
Pathologic Processes